Microtubules as a target for anticancer drugs (original) (raw)

• Luduena, R. F. Multiple forms of tubulin: different gene products and covalent modifications. Int. Rev. Cytology 178, 207–275 (1998). Comprehensive review of tubulin isotypes and post-translational modifications.
  CAS Google Scholar
• Verdier-Pinard, P. et al. Direct analysis of tubulin expression in cancer cell lines by electrospray ionization mass spectrometry. Biochemistry 42, 12019–12027 (2003). Describes analysis of tubulin isotypes, mutations and post-translational modifications by liquid chromatography/electrospray-ionization mass spectrometry in paclitaxel-sensitive and -resistant cell lines.
  CAS PubMed Google Scholar
• Ligon, L. A., Shelly, S. S., Tokito, M. & Holzbaur, E. L. The microtubule plus-end proteins EB1 and dynactin have differential effects on microtubule polymerization. Mol. Biol. Cell 14, 1405–1417 (2003).
  CAS PubMed PubMed Central Google Scholar
• Galmarini, C. M. et al. Drug resistance associated with loss of p53 involves extensive alterations in microtubule composition and dynamics. Br. J. Cancer 88, 1793–1799 (2003).
  CAS PubMed PubMed Central Google Scholar
• Giodini, A. et al. Regulation of microtubule stability and mitotic progression by survivin. Cancer Res. 62, 2462–2467 (2002).
  CAS PubMed Google Scholar
• Cassimeris, L. The oncoprotein 18/stathmin family of microtubule destabilizers. Curr. Opin. Cell Biol. 14, 18–24 (2002).
  CAS PubMed Google Scholar
• Spittle, C., Charrasse, S., Larroque, C. & Cassimeris, L. The interaction of TOGp with microtubules and tubulin. J. Biol. Chem. 275, 20748–20753 (2000).
  CAS PubMed Google Scholar
• Maney, T., Wagenbach, M. & Wordeman, L. Molecular dissection of the microtubule depolymerizing activity of mitotic centromere-associated kinesin. J. Biol. Chem. 276, 34753–34758 (2001).
  CAS PubMed Google Scholar
• Jordan, M. A. & Wilson, L. Microtubules and actin filaments: dynamic targets for cancer chemotherapy. Curr. Opin. Cell Biol. 10, 123–130 (1998).
  Article CAS PubMed Google Scholar
• Giannakakou, P., Sackett, D. & Fojo, T. Tubulin/microtubules: still a promising target for new chemotherapeutic agents. J. Natl Cancer Inst. 92, 182–183 (2000).
  CAS PubMed Google Scholar
• Gerzon, K. in Anticancer Agents Based on Natural Product Models (eds Cassady, J. M. & Douros, J. D.) 271–317 (Academic, New York, 1980).
  Google Scholar
• Wordeman, L. & Mitchison, T. J. in Microtubules (eds Hyams, J. S. & Lloyd, C. W.) 287–302 (Wiley–Liss, New York, 1994).
  Google Scholar
• Wilson, L. & Jordan, M. A. in Microtubules (eds Hyams, J. S. & Lloyd, C. W.) 59–84 (Wiley–Liss, New York, 1994).
  Google Scholar
• McIntosh, J. R. in Microtubules (eds Hyams, J. S. & Lloyd, C. W.) 413–434 (Wiley–Liss, New York, 1994).
  Google Scholar
• Waterman-Storer, C. & Salmon, E. D. Microtubule dynamics: treadmilling comes around again. Curr. Biol. 7, 369–372 (1997).
  Google Scholar
• Mitchison, T. J. & Kirschner, M. Dynamic instability of microtubule growth. Nature 312, 237–242 (1984).
  CAS PubMed Google Scholar
• Margolis, R. L. & Wilson, L. Opposite end assembly and disassembly of microtubules at steady state in vitro. Cell 13, 1–8 (1978).
  CAS PubMed Google Scholar
• Margolis, R. L. & Wilson, L. Microtubule treadmilling: what goes around comes around. Bioessays 20, 830–836 (1998).
  CAS PubMed Google Scholar
• Rodionov, V. I. & Borisy, G. G. Microtubule treadmilling in vivo. Science 275, 215–218 (1997).
  CAS PubMed Google Scholar
• Shaw, S. L., Kamyar, R. & Ehrhardt, D. W. Sustained microtubule treadmilling in Arabidopsis cortical arrays. Science 300, 1715–1718 (2003).
  CAS PubMed Google Scholar
• Panda, D., Miller, H. P. & Wilson, L. Rapid treadmilling of MAP-free brain microtubules in vitro and its suppression by tau. Proc. Natl Acad. Sci. USA 96, 12459–12464 (1999).
  CAS PubMed PubMed Central Google Scholar
• Chen, W. & Zhang, D. Kinetochore fibre dynamics outside the context of the spindle during anaphase. Nature Cell Biol. 6, 227–231 (2004). Demonstration of importance of treadmilling in anaphase-chromosome poleward movement and the independence of treadmilling from the spindle matrix.
  PubMed Google Scholar
• Wilson, L., Panda, D. & Jordan, M. A. Modulation of microtubule dynamics by drugs: a paradigm for the actions of cellular regulators. Cell Struct. Funct. 24, 329–335 (1999).
  CAS PubMed Google Scholar
• Nogales, E. Structural insights into microtubule function. Annu. Rev. Biophys. Biomol. Struct. 30, 397–420 (2001).
  CAS PubMed Google Scholar
• Wilson, L. & Jordan, M. A. Microtubule dynamics: taking aim at a moving target. Chem. Biol. 2, 569–573 (1995).
  CAS PubMed Google Scholar
• Lodish, H. et al. Molecular Cell Biology (W. H. Freeman, New York, 1999).
  Google Scholar
• Panda, D., Miller, H. & Wilson, L. Determination of the size and chemical nature of the stabilizing cap at microtubule ends using modulators of polymerization dynamics. Biochemistry 41, 1609–1617 (2002).
  CAS PubMed Google Scholar
• Caplow, M. & Fee, L. Concerning the chemical nature of tubulin subunits that cap and stabilize microtubules. Biochemistry 42, 2122–2126 (2003).
  CAS PubMed Google Scholar
• Panda, D., Miller, H. P. & Wilson, L. Rapid treadmilling of brain microtubules free of microtubule-associated proteins in vitro and its suppression by tau. Proc. Natl Acad. Sci. USA 96, 12459–12464 (1999).
  CAS PubMed PubMed Central Google Scholar
• Wittmann, T., Bokoch, G. & Waterman-Storer, C. Regulation of leading edge microtubule and actin dynamics downstream of Rac1. J. Cell Biol. 161, 845–851 (2003).
  CAS PubMed PubMed Central Google Scholar
• Alli, E., Bash-Babula, J., Yang, J. -M. & Hait, W. N. Effect of stathmin on the sensitivity to antimicrotubule drugs in human breast cancer. Cancer Res. 62, 6864–6869 (2002).
  CAS PubMed Google Scholar
• McNally, F. Microtubule dynamics: new surprises from an old MAP. Curr. Biol. 13, 597–599 (2003).
  Google Scholar
• Ohi, R., Coughlin, M. L., Lane, W. S. & Mitchison, T. J. An inner centromere protein that stimulates the microtubule depolymerizing activity of a KinI kinesin. Dev. Cell 5, 309–321 (2003).
  CAS PubMed Google Scholar
• Carvalho, P., Tirnauer, J. & Pellman, D. Surfing on microtubule ends. Trends Cell Biol. 13, 229–237 (2003).
  CAS PubMed Google Scholar
• Hergovich, A., Lisztwan, J., Barry, R., Ballschmieter, P. & Krek, W. Regulation of microtubule stability by the von Hippel–Lindau tumour suppressor protein pVHL. Nature Cell Biol. 5, 64–70 (2003).
  CAS PubMed Google Scholar
• Komarova, Y., Akhmanova, A., Kojima, S., Galjart, N. & Borisy, G. Cytoplasmic linker proteins promote microtubule rescue in vivo. J. Cell Biol. 159, 589–599 (2002).
  CAS PubMed PubMed Central Google Scholar
• Mitchison, T. J. Microtubule dynamics and kinetochore function in mitosis. Annu. Rev. Cell Biol. 4, 527–549 (1988).
  CAS PubMed Google Scholar
• Saxton, W. M. et al. Tubulin dynamics in cultured mammalian cells. J. Cell Biol. 99, 2175–2186 (1984).
  CAS PubMed Google Scholar
• Rusan, N. M., Fagerstrom, C. J., Yvon, A. -M. C. & Wadsworth, P. Cell cycle-dependent changes in microtubule dynamics in living cells expressing green fluorescent protein–α tubulin. Mol. Biol. Cell 12, 971–980 (2001).
  CAS PubMed PubMed Central Google Scholar
• Pepperkok, R., Bre, M. H., Davoust, J. & Kreis, T. E. Microtubules are stabilized in confluent epithelial cells but not in fibroblasts. J. Cell Biol. 111, 3003–3012 (1990).
  CAS PubMed Google Scholar
• Zhai, Y., Kronebusch, P. J., Simon, P. M. & Borisy, G. G. Microtubule dynamics at the G2/M transition: abrupt breakdown of cytoplasmic microtubules at nuclear envelope breakdown and implications for spindle morphogenesis. J. Cell Biol. 135, 201–214 (1996).
  CAS PubMed Google Scholar
• Hayden, J. J., Bowser, S. S. & Rieder, C. Kinetochores capture astral microtubules during chromosome attachment to the mitotic spindle: direct visualization in live newt cells. J. Cell Biol. 111, 1039–1045 (1990). Classic demonstration of the role of microtubule dynamic instability in the attachment of chromosomes to the mitotic spindle.
  CAS PubMed Google Scholar
• Jordan, M. A. et al. Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res. 56, 816–825 (1996). Demonstration that mitotic block by low concentrations of paclitaxel leads to apoptosis.
  CAS PubMed Google Scholar
• Rieder, C., Schultz, A., Cole, R. & Sluder, G. Anaphase onset in vertebrate somatic cells is controlled by a checkpoint that monitors sister kinetochore attachment to the spindle. J. Cell Biol. 127, 1301–1310 (1994).
  Article CAS PubMed Google Scholar
• Shelby, R. D., Hahn, K. M. & Sullivan, K. F. Dynamic elastic behavior of α-satellite DNA domains visualized in situ in living human cells. J. Cell Biol. 135, 545–557 (1996).
  CAS PubMed Google Scholar
• Mitchison, T. J. Poleward microtubule flux in the mitotic spindle; evidence from photoactivation of fluorescence. J. Cell Biol. 109, 637–652 (1989).
  CAS PubMed Google Scholar
• Wilson, P. J. & Forer, A. Effects of nanomolar taxol on crane-fly spermatocyte spindles indicate that acetylation of kinetochore microtubules can be used as a marker of poleward tubulin flux. Cell Motil. Cytoskeleton 37, 20–32 (1997).
  CAS PubMed Google Scholar
• Li, X. & Nicklas, R. B. Mitotic forces control a cell-cycle checkpoint. Nature 373, 630–632 (1995).
  CAS PubMed Google Scholar
• Nicklas, R. B., Ward, S. C. & Gorbsky, G. J. Kinetochore chemistry is sensitive to tension and may link mitotic forces to a cell cycle checkpoint. J. Cell Biol. 130, 929–939 (1995).
  CAS PubMed Google Scholar
• Gorbsky, G. J. Cell cycle checkpoints: arresting progress in mitosis. BioEssays 19, 193–197 (1997).
  CAS PubMed Google Scholar
• Zhou, J. et al. Brominated derivatives of noscapine are potent microtubule-interfering agents that perturb mitosis and inhibit cell proliferation. Mol. Pharmacol. 63, 799–807 (2003).
  CAS PubMed Google Scholar
• Hamel, E. & Covell, D. G. Antimitotic peptides and depsipeptides. Curr. Med. Chem. Anti-Canc. Agents 2, 19–53 (2002).
  CAS Google Scholar
• Hoffman, J. C. & Vaughn, K. C. Mitotic disrupter herbicides act by a single mechanism but vary in efficacy. Protoplasma 179, 16–25 (1994).
  CAS Google Scholar
• Lacey, E. & Gill, J. H. Biochemistry of benzimidazole resistance. Acta Trop. 56, 245–262 (1994).
  CAS PubMed Google Scholar
• Lobert, S., Ingram, J. & Correia, J. Additivity of dilantin and vinblastine inhibitory effects on microtubule assembly. Cancer Res. 59, 4816–4822 (1999).
  CAS PubMed Google Scholar
• Cann, J. R. & Hinman, N. D. Interaction of chlorpromazine with brain microtubule subunit protein. Molec. Pharmacol. 11, 256–267 (1975).
  CAS Google Scholar
• Boder, G. B., Paul, D. C. & Williams, D. C. Chlorpromazine inhibits mitosis of mammalian cells. Eur. J. Cell Biol. 31, 349–353 (1983).
  CAS PubMed Google Scholar
• Jordan, M. A. Mechanism of action of antitumor drugs that interact with microtubules and tubulin. Curr. Med. Chem. Anti-Canc. Agents 2, 1–17 (2002).
  CAS Google Scholar
• Jimenez-Barbero, J., Amat-Guerri, F. & Snyder, J. P. The solid state, solution and tubulin-bound conformations of agents that promote microtubule stabilization. Curr. Med. Chem. Anti-Canc. Agents 2, 91–122 (2002).
  CAS Google Scholar
• Jordan, M. A., Toso, R. J., Thrower, D. & Wilson, L. Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc. Natl Acad. Sci. USA 90, 9552–9556 (1993).
  CAS PubMed PubMed Central Google Scholar
• Chen, J. -G. & Horwitz, S. B. Differential mitotic responses to microtubule-stabilizing and -destabilizing drugs. Cancer Res. 62, 1935–1938 (2002).
  CAS PubMed Google Scholar
• Yvon, A. -M., Wadsworth, P. & Jordan, M. A. Taxol suppresses dynamics of individual microtubules in living human tumor cells. Mol. Biol. Cell 10, 947–949 (1999). First demonstration that suppression of microtubule dynamics in living cells by low concentrations of paclitaxel correlates with mitotic block.
  CAS PubMed PubMed Central Google Scholar
• Jordan, M. A. & Wilson, L. in Methods in Cell Biology, in Mitosis and Meiosis Vol. 61 (ed. Rieder, C. L.) 267–295 (Academic, New York, 1998).
  Google Scholar
• Skibbens, R. V., Skeen, V. P. & Salmon, E. D. Directional instability of kinetochore motility during chromosome congression and segregation in mitotic newt lung cells: a push-pull mechanism. J. Cell Biol. 122, 859–875 (1993).
  CAS PubMed Google Scholar
• Waters, J. C., Mitchison, T. J., Rieder, C. L. & Salmon, E. D. The kinetochore microtubule minus-end disassembly associated with poleward flux produces a force that can do work. Mol. Biol. Cell 7, 1547–1558 (1996).
  CAS PubMed PubMed Central Google Scholar
• Johnson, I. S., Wright, H. F. & Svoboda, G. H. Experimental basis for clinical evaluation of anti-tumor principles derived from Vinca rosea Linn. J. Lab. Clin. Med. 54, 830–837 (1959).
• Noble, R. L., Beer, C. T. & Cutts, J. H. Further biological activities of vincaleukoblastine: an alkaloid isolated from Vinca rosea (L.). Biochem. Pharmacol. 1, 347–348 (1958).
  Google Scholar
• Gidding, C. E., Kellie, S. J., Kamps, W. A. & de Graaf, S. S. Vincristine revisited. Crit. Rev. Oncol. Hematol. 29, 267–287 (1999).
  CAS PubMed Google Scholar
• Quasthoff, S. & Hartung, H. P. Chemotherapy-induced peripheral neuropathy. J. Neurol. 249, 9–17 (2002).
  CAS PubMed Google Scholar
• Sahenk, Z., Barohn, R., New, P. & Mendell, J. R. Taxol neuropathy. Electrodiagnostic and sural nerve biopsy findings. Arch. Neurol. 51, 726–729 (1994).
  CAS PubMed Google Scholar
• Jordan, M. A., Thrower, D. & Wilson, L. Mechanism of inhibition of cell proliferation by Vinca alkaloids. Cancer Res. 51, 2212–2222 (1991). First demonstration that antimitotic mechanism of Vinca alkaloids does not require microtubule depolymerization.
  CAS PubMed Google Scholar
• Bai, R. B., Pettit, G. R. & Hamel, E. Binding of dolastatin 10 to tubulin at a distinct site for peptide antimitotic agents near the exchangeable nucleotide and Vinca alkaloid sites. J. Biol. Chem. 265, 17141–17149 (1990).
  CAS PubMed Google Scholar
• Wilson, L., Jordan, M. A., Morse, A. & Margolis, R. L. Interaction of vinblastine with steady-state microtubules in vitro. J. Mol. Biol. 159, 125–149 (1982).
  CAS PubMed Google Scholar
• Jordan, M. A. & Wilson, L. Kinetic analysis of tubulin exchange at microtubule ends at low vinblastine concentrations. Biochemistry 29, 2730–2739 (1990).
  CAS PubMed Google Scholar
• Na, G. C. & Timasheff, S. N. Thermodynamic linkage between tubulin self-association and the binding of vinblastine. Biochemistry 19, 1347–1354 (1980).
  CAS PubMed Google Scholar
• Na, G. C. & Timasheff, S. N. Stoichiometry of the vinblastine-induced self-association of calf brain tubulin. Biochemistry 19, 1347–1354 (1980).
  CAS PubMed Google Scholar
• Lobert, S. & Correia, J. in Methods in Enzymology Vol. 323, (ed. Johnson, M.) 77–103 (Academic Press, 2000).
  Google Scholar
• Jordan, M. A., Margolis, R. L., Himes, R. H. & Wilson, L. Identification of a distinct class of vinblastine binding sites on microtubules. J. Mol. Biol. 187, 61–73 (1986).
  CAS PubMed Google Scholar
• Singer, W. D., Jordan, M. A., Wilson, L. & Himes, R. H. Binding of vinblastine to stabilized microtubules. Mol. Pharmacol. 36, 366–370 (1989).
  CAS PubMed Google Scholar
• Wani, M. C., Taylor, H. L., Wall, M. E., Coggon, P. & McPhail, A. T. J. Am. Chem. Soc. 93, 2325–2327 (1971).
  CAS PubMed Google Scholar
• Schiff, P. B., Fant, J. & Horwitz, S. B. Promotion of microtubule assembly in vitro by taxol. Nature 277, 665–667 (1979). Classic demonstration that paclitaxel enhances microtubule polymerization and stabilizes microtubules.
  CAS PubMed Google Scholar
• Horwitz, S. B. How to make taxol from scratch. Nature 367, 593–594 (1994).
  CAS PubMed Google Scholar
• Von Hoff, D. D. The taxoids: same roots, different drugs. Semin. Oncol. 24 (4 Suppl. 13), S13-3–S13-10 (1997).
  Google Scholar
• Markman, M. Managing taxane toxicities. Support Care Cancer 11, 144–147 (2003).
  PubMed Google Scholar
• Nogales, E., Wolf, S. G., Khan, I. A., Luduena, R. F. & Downing, K. A. Structure of tubulin at 6.5Å and location of the taxol-binding site. Nature 375, 424–427 (1995). First high-resolution determination of the structure of polymerized tubulin and the paclitaxel-binding site.
  CAS PubMed Google Scholar
• Derry, W. B., Wilson, L. & Jordan, M. A. Substoichiometric binding of taxol suppresses microtubule dynamics. Biochemistry 34, 2203–2211 (1995). Mechanistic analysis of suppression of microtubule dynamics by paclitaxel.
  CAS PubMed Google Scholar
• Kelling, J., Sullivan, K., Wilson, L. & Jordan, M. A. Suppression of centromere dynamics by taxol in living osteosarcoma cells. Cancer Res. 63, 2794–2801 (2003).
  CAS PubMed Google Scholar
• Pryor, D. E. et al. The microtubule stabilizing agent laulimalide does not bind in the taxoid site, kills cells resistant to paclitaxel and epothilones, and may not require its epoxide moiety for activity. Biochemistry 41, 9109–9115 (2002).
  CAS PubMed Google Scholar
• Hastie, S. B. Interactions of colchicine with tubulin. Pharmacol. Ther. 512, 377–401 (1991).
  Google Scholar
• Skoufias, D. & Wilson, L. Mechanism of inhibition of microtubule polymerization by colchicine: inhibitory potencies of unliganded colchicine and tubulin–colchicine complexes. Biochemistry 31, 738–746 (1992).
  CAS PubMed Google Scholar
• Tozer, G. M., Kanthou, C., Parkins, C. S. & Hill, S. A. The biology of the combretastatins as tumour vascular targeting agents. Int. J. Exp. Pathol. 83, 21–38 (2002). Review of mechanism of action of combretastatins and their therapeutic potential.
  CAS PubMed PubMed Central Google Scholar
• Kanthou, C. & Tozer, G. M. The tumor vascular targeting agent combretastatin A-4-phosphate induces reorganization of the actin cytoskeleton and early membrane blebbing in human endothelial cells. Blood 99, 2060–2069 (2002).
  CAS PubMed Google Scholar
• Tozer, G. M. et al. Mechanisms associated with tumor vascular shut-down induced by combretastatin A-4 phosphate: intravital microscopy and measurement of vascular permeability. Cancer Res. 61, 6413–6422 (2001).
  CAS PubMed Google Scholar
• Prise, V. E., Honess, D. J., Stratford, M. R., Wilson, J. & Tozer, G. M. The vascular response of tumor and normal tissues in the rat to the vascular targeting agent, combretastatin A-4-phosphate, at clinically relevant doses. Int. J. Oncol. 21, 717–726 (2002).
  CAS PubMed Google Scholar
• Davis, P. D. et al. ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculature. Cancer Res. 62, 7247–7253 (2002).
  CAS PubMed Google Scholar
• Dumontet, C. & Sikic, B. Mechanisms of action of and resistance to antitubulin agents: microtubule dynamics, drug transport, and cell death. J. Clin. Oncol. 17, 1061–1070 (1999).
  CAS PubMed Google Scholar
• Ambudkar, S. V., Kimchi-Sarfaty, C., Sauna, Z. E. & Gottesman, M. M. P-glycoprotein: from genomics to mechanism. Oncogene 22, 7468–7485 (2003).
  CAS PubMed Google Scholar
• Safa, A. R. Identification and characterization of the binding sites of P-glycoprotein for multidrug resistance-related drugs and modulators. Curr. Med. Chem. Anti-Canc. Agents 4, 1–17 (2004).
  CAS Google Scholar
• Thomas, H. & Coley, H. M. Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoprotein. Cancer Control 10, 159–165 (2003).
  PubMed Google Scholar
• Geney, R., Ungureanu, M., Li, D. & Ojima, I. Overcoming multidrug resistance in taxane chemotherapy. Clin. Chem. Lab. Med. 40, 918–925 (2002).
  CAS PubMed Google Scholar
• Orr, G. A., Verdier-Pinard, P., McDaid, H. & Horwitz, S. B. Mechanisms of taxol resistance related to microtubules. Oncogene 22, 7280–7295 (2003). Comprehensive review of microtubule-related mechanisms of paclitaxel resistance.
  CAS PubMed PubMed Central Google Scholar
• Kavallaris, M. et al. Multiple microtubule alterations are associated with Vinca alkaloid resistance in human leukemia cells. Cancer Res. 61, 5803–5809 (2001).
  CAS PubMed Google Scholar
• Minotti, A. M., Barlow, S. B. & Cabral, F. Resistance to antimitotic drugs in Chinese hamster ovary cells correlated with changes in the level of polymerized tubulin. J. Biol. Chem. 266, 3987–3994 (1991).
  CAS PubMed Google Scholar
• James, S. W., Silflow, C. D., Stroom, P. & Lefebvre, P. A. A mutation in the α1-tubulin gene of Chlamydomonas reinhardtii confers resistance to anti-microtubule herbicides. J. Cell Sci. 106, 209–218 (1993).
  CAS PubMed Google Scholar
• Lee, W. -P. Purification and characterization of tubulin from parental and vincristine-resistant HOB1 lymphoma cells. Arch. Biochem. Biophys. 319, 498–503 (1995).
  CAS PubMed Google Scholar
• Ohta, S. et al. Characterization of a taxol-resistant human small-cell lung cancer cell line. Jpn. J. Cancer Res. 85, 290–297 (1994).
  CAS PubMed PubMed Central Google Scholar
• Laing, N. M. et al. Amplification of the ATP-binding cassette 2 transporter gene is functionally linked with enhanced efflux of estramustine in ovarian carcinoma cells. Cancer Res. 58, 1332–1337 (1998).
  CAS PubMed Google Scholar
• Burkhart, C. A., Kavallaris, M. & Band Horwitz, S. The role of β-tubulin isotypes in resistance to antimitotic drugs. Biochim. Biophys. Acta. 1471, O1–O9 (2001).
  CAS PubMed Google Scholar
• Dumontet, C. et al. Resistance to microtubule–targeted cytotoxins in a K562 leukemia cell variant is associated with altered tubulin expression. Elec. J. Oncol. 2, 33–44 (1999).
  Google Scholar
• Giannakakou, P. et al. A common pharmacophore for epothilone and taxanes: molecular basis for drug resistance conferred by tubulin mutations in human cancer cells. Proc. Natl Acad. Sci. USA 97, 2904–2909 (2000).
  CAS PubMed PubMed Central Google Scholar
• Goncalves, A. et al. Resistance to taxol in lung cancer cells associated with increased microtubule dynamics. Proc. Natl Acad. Sci. USA 98, 11737–11741 (2001). First demonstration of sensitivity of mitotic progression to precise regulation of microtubule dynamics and of the association of increased microtubule dynamics with paclitaxel resistance.
  CAS PubMed PubMed Central Google Scholar
• Haber, M. et al. Altered expression of Mβ2, the class II β-tubulin isotype, in a murine J774.2 cell line with a high level of taxol resistance. J. Biol. Chem. 270, 31269–31275 (1995).
  CAS PubMed Google Scholar
• Jaffrezou, J. -P. et al. Novel mechanism of resistance to paclitaxel in human K562 leukemia cells by combined selection with PSC833. Oncology Res. 7, 517–527 (1995).
  CAS Google Scholar
• Kavallaris, M. et al. Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific β-tubulin isotypes. J. Clin. Invest. 100, 1–12 (1997).
  Google Scholar
• Poruchynsky, M. S. et al. Accompanying protein alterations in malignant cells with a microtubule- polymerizing drug-resistance phenotype and a primary resistance mechanism. Biochem. Pharmacol. 62, 1469–1480 (2001).
  CAS PubMed Google Scholar
• Ranganathan, S. et al. Increase of βIII- and βIVa-tubulin isotypes in human prostate carcinoma cells as a result of estramustine resistance. Cancer Res. 56, 2584–2589 (1996).
  CAS PubMed Google Scholar
• Verdier-Pinard, P. et al. Analysis of tubulin isotypes and mutations from taxol-resistant cells by combined isoelectrofocusing and mass spectrometry. Biochemistry 42, 5349–5357 (2003).
  CAS PubMed Google Scholar
• Kavallaris, M., Burkhardt, C. A. & Horwitz, S. B. Antisense oligonucleotides to class III β-tubulin sensitize drug-resistant cells to Taxol. Br. J. Cancer 80, 1020–1025 (1999).
  CAS PubMed PubMed Central Google Scholar
• Martello, L. A. et al. Taxol and discodermolide represent a synergistic drug combination in human carcinoma cell lines. Clin. Cancer Res. 6, 1978–1987 (2000).
  CAS PubMed Google Scholar
• Martello, L. A. et al. Elevated levels of microtubule destabilizing factors in a taxol-resistant/dependent A549 cell line with an α-tubulin mutation. Cancer Res. 63, 1207–1213 (2003).
  CAS PubMed Google Scholar
• Wendell, K. L., Wilson, L. & Jordan, M. A. Mitotic block in HeLa cells by vinblastine: ultrastructural changes in kinetochore-microtubule attachment and in centrosomes. J. Cell Sci. 104, 261–274 (1993).
  CAS PubMed Google Scholar
• Panda, D., Miller, H., Islam, K. & Wilson, L. Stabilization of microtubule dynamics by estramustine by binding to a novel site in tubulin: a possible mechanistic basis for its antitumor action. Proc. Natl Acad. Sci. USA 94, 10560–10564 (1997).
  CAS PubMed PubMed Central Google Scholar
• Seidman, A., Scher, H. I., Petrylak, D., Derrshaw, D. D. & Curley, T. Estramustine and vinblastine: use of prostate specific antigen as a clinical trial end point for hormone refractory prostatic cancer. J. Urol. 147, 931–934 (1992).
  CAS PubMed Google Scholar
• Hudes, G. R. et al. Phase II study of estramustine and vinblastine, two microtubule inhibitors, in hormone-refractory prostate cancer. J. Clin. Oncol. 10, 1754–1761 (1992).
  CAS PubMed Google Scholar
• Hudes, G. R. et al. Paclitaxel plus estramustine in metastatic hormone-refractory prostate cancer. Semin. Oncol. 22, 41–45 (1995).
  CAS PubMed Google Scholar
• Knick, V. C., Eberwein, D. & Miller, C. Vinorelbine tartrate and paclitaxel combinations: enhanced activity against in vivo P388 murine leukemia cells. J. Natl Cancer Inst. 87, 1072–1077 (1995).
  CAS PubMed Google Scholar
• Photiou, A., Shah, P., Leong, L., Moss, J. & Retsas, S. In vitro synergy of paclitaxel (Taxol) and vinorelbine (navelbine) against human melanoma cell lines. Eur. J. Cancer 33, 463–470 (1997).
  CAS PubMed Google Scholar
• Dieras, V. et al. Docetaxel in combination with doxorubicin or vinorelbine. Eur. J. Cancer 33 (Suppl 7), 20–22 (1997).
  Google Scholar
• Garcia, P., Braguer, D., Carles, G. & Briand, C. Simultaneous combination of microtubule depolymerizing and stabilizing agents acts at low doses. Anticancer Drugs 6, 533–544 (1995).
  CAS PubMed Google Scholar
• Giannakakou, P., Villalba, L., Li, H., Poruchynsky, M. & Fojo, T. Combinations of paclitaxel and vinblastine and their effects on tubulin polymerization and cellular cytotoxicity: characterization of a synergistic schedule. Int. J. Cancer 75, 57–63 (1998).
  CAS PubMed Google Scholar
• Duflos, A., Kruczynski, A. & Barret, J. -M. Novel aspects of natural and modified Vinca alkaloids. Curr. Med. Chem. Anti-Canc. Agents 2, 55–70 (2002).
  CAS Google Scholar
• Plosker, G. L. & Figgitt, D. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia. Drugs 63, 803–843 (2003).
  CAS PubMed Google Scholar
• Sandler, A. B. Chemotherapy for small cell lung cancer. Semin. Oncol. 30, 9–25 (2003).
  CAS PubMed Google Scholar
• Armitage, J. O. Overview of rational and individualized therapeutic strategies for non-Hodgkin's lymphomas. Clin. Lymphoma 3, S5–S11 (2002).
  PubMed Google Scholar
• Jassem, J. et al. Oral vinorelbine in combination with cisplatin: a novel active regimen in advanced non-small-cell lung cancer. Ann. Oncol. 14, 1634–1639 (2003).
  CAS PubMed Google Scholar
• Rossi, A. et al. Single agent vinorelbine as first-line chemotherapy in elderly patients with advanced breast cancer. Anticancer Res. 23, 1657–1664 (2003).
  CAS PubMed Google Scholar
• Seidman, A. D. Monotherapy options in the management of metastatic breast cancer. Semin. Oncol. 30, 6–10 (2003).
  CAS PubMed Google Scholar
• Okouneva, T., Hill, B. T., Wilson, L. & Jordan, M. A. The effects of vinflunine, vinorelbine, and vinblastine on centromere dynamics. Mol. Cancer Ther. 2, 427–436 (2003).
  CAS PubMed Google Scholar
• Panda, D. et al. Interaction of the antitumor compound cryptophycin-52 with tubulin. Biochemistry 39, 14121–14127 (2000).
  CAS PubMed Google Scholar
• Kerksiek, K., Mejillano, M. R., Schwartz, R. E., Georg, G. I. & Himes, R. H. Interaction of cryptophycin 1 with tubulin and microtubules. FEBS Lett. 377, 59–61 (1995).
  CAS PubMed Google Scholar
• Bai, R. B. et al. Halichondrin B and homohalichondrin B, marine natural products binding in the Vinca domain of tubulin. Discovery of tubulin-based mechanism of action by analysis of differential cytotoxicity data. J. Biol. Chem. 266, 15882–15889 (1991).
  CAS PubMed Google Scholar
• Luduena, R. F., Roach, M. C., Prasad, V. & Pettit, G. R. Interaction of halichondrin B and homohalichondrin B with bovine brain tubulin. Biochem. Pharmacol. 45, 421–427 (1993).
  CAS PubMed Google Scholar
• Towle, M. J. et al. In vitro and in vivo anticancer activities of synthetic macrocyclic ketone analogs of halichondrin B. Cancer Res. 61, 1013–1021 (2001).
  CAS PubMed Google Scholar
• Hamel, E. Natural products which interact with tubulin in the Vinca domain: maytansine, rhizoxin, phomopsin A, Dolastatins 10 and 15 and halichondrin B. Pharmacol. Ther. 55, 31–51 (1992).
  CAS PubMed Google Scholar
• Bai, R., Durso, N. A., Sackett, D. L. & Hamel, E. Interactions of the sponge-derived antimitotic tripeptide hemiasterlin with tubulin: comparison with dolastatin 10 and cryptophycin 1. Biochemistry 38, 14302–14310 (1999).
  CAS PubMed Google Scholar
• Loganzo, F. et al. HTI-286, a synthetic analogue of the tripeptide hemiasterlin, is a potent antimicrotubule agent that circumvents P-glycoprotein-mediated resistance in vitro and in vivo. Cancer Res. 63, 1838–1845 (2003).
  CAS PubMed Google Scholar
• Hamel, E. et al. Antitumor 2,3-dihydro-2-(aryl)-4(1H)-quinazolinone derivatives. Interactions with tubulin. Biochem. Pharmacol. 51, 53–59 (1996).
  CAS PubMed Google Scholar
• Mabjeesh, N. J. et al. 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell 3, 363–375 (2003).
  CAS PubMed Google Scholar
• Lakhani, N. J., Sarkar, M. A., Venitz, J. & Figg, W. D. 2-Methoxyestradiol, a promising anticancer agent. Pharmacotherapy 23, 165–172 (2003).
  CAS PubMed Google Scholar
• Yoshimatsu, K., Yamaguchi, A., Yoshino, H., Koyanagi, N. & Kitoh, K. Mechanism of action of E7010, an orally active sulfonamide antitumor agent: inhibition of mitosis by binding to the colchicine site of tubulin. Cancer Res. 57, 3208–3213 (1997).
  CAS PubMed Google Scholar
• Manfredi, J. J., Parness, J. & Horwitz, S. B. Taxol binds to cell microtubules. J. Cell Biol. 94, 688–696 (1982).
  CAS PubMed Google Scholar
• Parness, J. & Horwitz, S. B. Taxol binds to polymerized tubulin in vitro. J. Cell Biol. 91, 479–487 (1981).
  CAS PubMed PubMed Central Google Scholar
• Diaz, J. F. & Andreu, J. M. Assembly of purified GDP-tubulin into microtubules induced by taxol and taxotere: reversibility, ligand stoichiometry, and competition. Biochemistry 32, 2747–2755 (1993).
  CAS PubMed Google Scholar
• Belani, C. P., Langer, C. TAX 326 Study Group. First-line chemotherapy for NSCLC: an overview of relevant trials. Lung Cancer 38 (Suppl. 4), 13–19 (2002).
  PubMed Google Scholar
• Fossella, F. V., Lynch, T. & Shepherd, F. A. Second line chemotherapy for NSCLC: establishing a gold standard. Lung Cancer 38, 5–12 (2002).
  PubMed Google Scholar
• Bollag, D. M. et al. Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action. Cancer Res. 55, 2325–2333 (1995).
  CAS PubMed Google Scholar
• Wartmann, M. & Altmann, K. H. The biology and medicinal chemistry of epothilones. Curr. Med. Chem. Anti-Canc. Agents 2, 123–148 (2002).
  CAS Google Scholar
• Lee, F. Y. et al. BMS-247550: a novel epothilone analog with a mode of action similar to apclitaxel but possessing superior sntiumor efficacy. Clin. Cancer Res. 7, 1429–1437 (2001).
  CAS PubMed Google Scholar
• Kamath, K. & Jordan, M. A. Suppression of microtubule dynamics by epothilone B in living MCF7 cells. Cancer Res. 63, 6026–6031 (2003).
  CAS PubMed Google Scholar
• ter Haar, E. et al. Discodermolide, a cytotoxic marine agent that stabilizes microtubules more potently than taxol. Biochemistry 35, 243–250 (1996).
  CAS PubMed Google Scholar
• Honore, S. et al. Suppression of microtubule dynamics by discodermolide by a novel mechanism is associated with mitotic arrest and inhibition of tumor cell proliferation. Mol. Cancer Ther. 2, 1303–1311 (2003).
  CAS PubMed Google Scholar
• Hung, D. T., Chen, J. & Schreiber, S. L. (+)-Discodermolide binds to microtubules in stoichiometric ratio to tubulin dimers, blocks taxol binding and results in mitotic arrest. Chem. Biol. 3, 287–293 (1996).
  CAS PubMed Google Scholar
• Kavallaris, M., Verrills, N. M. & Hill, B. T. Anticancer therapy with novel tubulin-interacting drugs. Drug Resist. Update 4, 392–401 (2001).
  CAS Google Scholar
• Kowalski, R. J. et al. The microtubule-stabilizing agent discodermolide competitively inhibits the binding of paclitaxel (Taxol) to tubulin polymers, enhances tubulin nucleation reactions more potently than paclitaxel, and inhibits the growth of paclitaxel-resistant cells. Mol. Pharmacol. 52, 613–622 (1997).
  CAS PubMed Google Scholar
• Smaletz, O. et al. Pilot study of epothilone B analog (BMS–247550) and estramustine phosphate in patients with progressive metastatic prostate cancer following castration. Ann. Oncol. 14, 1518–1524 (2003).
  CAS PubMed Google Scholar
• Kelly, W. et al. Dose escalation study of intravenous estramustine phosphate in combination with Paclitaxel and Carboplatin in patients with advanced prostate cancer. Clin. Cancer Res. 9, 2098–2107 (2003).
  CAS PubMed Google Scholar
• Hudes, G. et al. Phase I clinical and pharmacologic trial of intravenous estramustine phosphate. J. Clin. Oncol. 20, 1115–1127 (2002).
  CAS PubMed Google Scholar
• Dahllof, B., Billstron, A., Cabral, F. & Hartley-Asp, B. Estramustine depolymerizes microtubules by binding to tubulin. Cancer Res. 53, 4573–4581 (1993).
  CAS PubMed Google Scholar